World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
28516
World Ranking
9805
National Ranking
5040

Overview

A. John Barrett is a researcher affiliated with the National Institutes of Health in the United States. Their work primarily focuses on the field of Medicine, with subfields covering Hematology, Oncology, Genetics, Cardiology and Cardiovascular Medicine, as well as Public Health, Environmental and Occupational Health.

The scientist's research topics encompass various aspects of hematologic and oncologic conditions and treatments. These include:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Hematopoietic Stem Cell Transplantation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Pancreatic function and diabetes

Among their recent publications are studies presented across multiple respected journals. The following papers illustrate the scope and variety of their research:

  • "Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT," published in 2022 in Blood Advances
  • "Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors," published in 2020 in Clinical Hematology International
  • "Functional Characterization of Glucokinase Variants to Aid Clinical Interpretation of Monogenic Diabetes," published in 2025 in International Journal of Molecular Sciences

Frequent collaborators in Barrett's recent work include Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojević, and Carolina Colli Cruz. These co-authors have partnered on studies likely linked to the main avenues of hematology and oncology research that Barrett pursues.

The scientist's publications have appeared repeatedly in journals such as Blood Advances, Clinical Hematology International, and International Journal of Molecular Sciences, indicating ongoing engagement with audiences in clinical hematology, oncology, and molecular biology.

Best Publications

  • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

    Childs R;Chernoff A;Contentin N;Bahceci E

  • Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

    R. Childs;E. Clave;N. Contentin;D. Jayasekera

  • Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

    Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden

  • Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

    Conrad Russell Y. Cruz;Kenneth P. Micklethwaite;Barbara Savoldo;Carlos A. Ramos

  • Graft-versus-leukemia reactions in allogeneic chimeras

    Hans-Jochem Kolb;Hans-Jochem Kolb;Christoph Schmid;Christoph Schmid;A. John Barrett;A. John Barrett;Dolores J. Schendel;Dolores J. Schendel

  • Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis

    Pierre Teira;Minoo Battiwalla;Muthalagu Ramanathan;A. John Barrett

  • High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

    Katayoun Rezvani;Stephan Mielke;Mojgan Ahmadzadeh;Yasemin Kilical

  • Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

    Katayoun Rezvani;Agnes S.M. Yong;Stephan Mielke;Bipin N. Savani

  • Hepatitis-Associated Aplastic Anemia

    K E Brown;J Tisdale;A J Barrett;C E Dunbar

  • Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

    Maryalice Stetler-Stevenson;Diane C. Arthur;Nicholas Jabbour;Xiu Y. Xie

  • HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

    Yogen Saunthararajah;Ryotaro Nakamura;Jun Mo Nam;Jamie Robyn

  • Antithymocyte globulin for patients with myelodysplastic syndrome

    Jeffrey J. Molldrem;Mary Caples;Dimitrios Mavroudis;Michelle Plante

  • Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

    Katayoun Rezvani;Matthias Grube;Matthias Grube;Jason M. Brenchley;Jason M. Brenchley;Giuseppe Sconocchia;Giuseppe Sconocchia

  • Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation

    John E. Levine;Thomas Braun;Samuel L. Penza;Patrick Beatty

  • Deficient CD4 + CD25 + FOXP3 + T regulatory cells in acquired aplastic anemia

    Elena E. Solomou;Katayoun Rezvani;Stephan Mielke;Daniela Malide

  • Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

    Geoff Hale;Mei-Jie Zhang;Donald Bunjes;H. Grant Prentice

  • Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units

    Jeffrey J. Molldrem;Emmanuel Clave;Yin Zheng Jiang;Dimitrios Mavroudis

  • Antithymocyte Globulin for Treatment of the Bone Marrow Failure Associated with Myelodysplastic Syndromes

    Jeffrey J. Molldrem;Eric Leifer;Erkut Bahceci;Yogen Saunthararajah

  • Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission

    A. John Barrett;Mary M. Horowitz;Bradley H Pollock;Mei Jie Zhang

  • Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.

    Jean-Yves Cahn;John P. Klein;Stephanie J. Lee;Noël Milpied

Frequent Co-Authors

Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
J. Joseph Melenhorst
J. Joseph Melenhorst University of Pennsylvania
Richard Childs
Richard Childs National Institutes of Health
David Price
David Price University of Aberdeen
Neal S. Young
Neal S. Young National Institutes of Health
Daniel C. Douek
Daniel C. Douek National Institute of Allergy and Infectious Diseases
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Emma Gostick
Emma Gostick Cardiff University
Catherine M. Bollard
Catherine M. Bollard George Washington University
David F. Stroncek
David F. Stroncek National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but looking for more flexible or affordable options, there are several related online degrees you can explore. For those who want to focus on healthcare administration and digital records, a bachelor of health information management online offers training in managing patient data and information systems.

Another pathway is medical administration. You can start by taking medical billing and coding classes online, which prepare you for roles handling insurance claims, coding medical procedures, and supporting clinics or hospitals behind the scenes.

If nursing is your passion, becoming a nurse practitioner offers a high level of autonomy and opportunity. There are cheap online fnp programs available, letting you pursue this advanced role without the traditional classroom setting. Alternatively, if you're aiming to quickly transition into nursing practice, consider the cheapest online accelerated bsn programs to fast-track your education.

These flexible online degrees and certifications open many doors in the healthcare industry — often with lower costs and greater work-life balance.

Best Scientists Citing A. John Barrett

Trending Scientists

Recently Published Articles